Bicycle Therapeutics (BCYC) Receivables - Net (2018 - 2025)

Bicycle Therapeutics (BCYC) has 8 years of Receivables - Net data on file, last reported at $136000.0 in Q1 2025.

• Quarterly Receivables - Net changed N/A year-over-year to $136000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $136000.0 (changed N/A YoY) and the FY2022 annual result came in at $2.0 million, up 104.5% from the prior year.
• Receivables - Net slipped to $136000.0 in Q1 2025, from $233000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $50.0 million in Q1 2023 to a low of $136000.0 in Q1 2025.
• A 5-year average of $13.8 million and a median of $2.0 million in 2021 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net soared 350.9% — and 2024, when it sank 99.48%.
• Tracing BCYC's Receivables - Net over 5 years: stood at $1.0 million in 2021, then jumped by 104.5% to $2.0 million in 2022, then surged by 2104.89% to $45.1 million in 2023, then slumped by 99.48% to $233000.0 in 2024, then tumbled by 41.63% to $136000.0 in 2025.
• The last three Receivables - Net figures came in at $136000.0 (Q1 2025), $233000.0 (Q2 2024), and $45.1 million (Q2 2023), per Business Quant data.